Please provide your email address to receive an email when new articles are posted on . Researchers validated a liver cancer risk test algorithm for identifying patients with chronic hepatitis C at ...

New research finds that machine-learning algorithms can help health care staff distinguish the two conditions. Researchers show how algorithms may be effective predictive tools using a few simple ...

Hepatitis C is the leading blood borne infection, and the number one cause of liver disease in the United States. The Center for Disease Control estimates that 2.7 million people in the US are ...

For decades, many Americans with hepatitis C have struggled to get tested or died waiting for a cure that remained inaccessibly expensive within the nation’s fractured health care system. President ...

Epclusa (sofosbuvir/velpatasvir) is a brand-name prescription medication. It’s approved by the Food and Drug Administration (FDA) to treat hepatitis C, which is an ...

Despite an arsenal of drugs, many Americans are still unaware of their infections until it’s too late. A Biden initiative languishes without Congressional approval. By Ted Alcorn In the 10 years since ...